(Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc/BioNTech SE COVID-19 vaccine for people aged 16 and older.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Leslie Adler)
